%0 Journal Article %1 noauthororeditor %A |, SABIROVA D.B. %D 2023 %J CENTRAL ASIAN JOURNAL OF MEDICAL AND NATURAL SCIENCE %K Visque, age-related, coherence degeneration, drug, injections intraocular macular, optical, tomography, %N 6 %P 329-335 %T The Use of The Drug Visque in Age-Related Macular Degeneration of The Retina %U https://cajmns.centralasianstudies.org/index.php/CAJMNS/article/view/2039/2093 %V 4 %X The study involved 25 patients (25 eyes) with nAMD (neovascular age-related macular degeneration). Among them were 13 women, 12 men. The inclusion criteria for the study were: the presence of active CNV, the absence of any previous antiangiogenic therapy. Non-inclusion criteria: a history of previous antiangiogenic therapy.The study was conducted at Yusupov A.A. Clinic LLC. In addition to standard examination methods, all patients underwent optical coherence tomography (OCT) using the RS-3000 Advance2 instrument (NIDEK, Japan). In the angiography mode (angio-OCT), the localization and area of the neovascular complex, the density and thickness of the newly formed vessels, the branching and perfusion of the subretinal neovascular membrane were determined, and their dynamics after treatment was assessed. In addition, retinal photosensitivity was assessed using Maia microperimetry (CenterVue, Italy). All patients underwent intraocular injections of Vizque® according to the standard loading scheme - 3 monthly injections. All of them were performed by one surgeon in a sterile operating room in accordance with the instructions for the medical use of the drug (at a dose of 6.0 mg / 0.05 ml).

@article{noauthororeditor, abstract = {The study involved 25 patients (25 eyes) with nAMD (neovascular age-related macular degeneration). Among them were 13 women, 12 men. The inclusion criteria for the study were: the presence of active CNV, the absence of any previous antiangiogenic therapy. Non-inclusion criteria: a history of previous antiangiogenic therapy.The study was conducted at Yusupov A.A. Clinic LLC. In addition to standard examination methods, all patients underwent optical coherence tomography (OCT) using the RS-3000 Advance2 instrument (NIDEK, Japan). In the angiography mode (angio-OCT), the localization and area of the neovascular complex, the density and thickness of the newly formed vessels, the branching and perfusion of the subretinal neovascular membrane were determined, and their dynamics after treatment was assessed. In addition, retinal photosensitivity was assessed using Maia microperimetry (CenterVue, Italy). All patients underwent intraocular injections of Vizque® according to the standard loading scheme - 3 monthly injections. All of them were performed by one surgeon in a sterile operating room in accordance with the instructions for the medical use of the drug (at a dose of 6.0 mg / 0.05 ml).}, added-at = {2024-02-07T13:24:22.000+0100}, author = {|, SABIROVA D.B.}, biburl = {https://www.bibsonomy.org/bibtex/27c72f1ea378d2defcdbf19fa687ca6f8/centralasian_20}, interhash = {77d386708016244dd58011014df28261}, intrahash = {7c72f1ea378d2defcdbf19fa687ca6f8}, issn = {2660-4159}, journal = {CENTRAL ASIAN JOURNAL OF MEDICAL AND NATURAL SCIENCE}, keywords = {Visque, age-related, coherence degeneration, drug, injections intraocular macular, optical, tomography,}, language = {english}, month = dec, number = 6, pages = {329-335}, timestamp = {2024-02-07T13:24:22.000+0100}, title = {The Use of The Drug Visque in Age-Related Macular Degeneration of The Retina}, url = {https://cajmns.centralasianstudies.org/index.php/CAJMNS/article/view/2039/2093}, volume = 4, year = 2023 }